Related content

Concurrent pernicious anemia and myelodysplastic syndrome

By Drabick Joseph J.   Davis Brad J.   Byrd John C.  

Annals of Hematology, Vol. 80, Iss. 4, 2001-04 ,pp. : 243-245

Springer Publishing Company

Access to resources Recommend Favorite

Detection of Small Populations of CD59-Deficient Erythrocytes in Patients with Aplastic Anemia or Myelodysplastic Syndrome and Normal Individuals

By Yamaguchi M.   Machii T.   Azenishi Y.   Nishimura J.   Shibano M.   Kanakura Y.   Kitani T.  

Blood Cells, Molecules, and Diseases, Vol. 26, Iss. 3, 2000-06 ,pp. : 247-254

Academic Press

Access to resources Recommend Favorite

Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia

By Kuendgen Andrea   Knipp Sabine   Fox Frank   Strupp Corinna   Hildebrandt Barbara   Steidl Christian   Germing Ulrich   Haas Rainer   Gattermann Norbert  

Annals of Hematology, Vol. 84, Iss. 1, 2005-12 ,pp. : 61-66

Springer Publishing Company

Access to resources Recommend Favorite

Spontaneous remission of 2-chlorodeoxyadenosine (2-CdA)-related secondary myelodysplastic syndrome in a patient with refractory Langerhans cell histiocytosis

By Suzuki Daisuke  

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 782-785

Springer Publishing Company

Access to resources Recommend Favorite

Autologous lymphocytes inhibit hemopoiesis in long-term culture in patients with myelodysplastic syndrome

By Baumann I.   Scheid C.   Koref M.S.   Swindell R.   Stern P.   Testa N.G.  

Experimental Hematology, Vol. 30, Iss. 12, 2002-12 ,pp. : 1405-1411

Elsevier

Access to resources Recommend Favorite